株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の髄膜炎菌ワクチン市場:2018年〜2025年

Global Meningococcal Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

発行 QYResearch 商品コード 698998
出版日 ページ情報 英文 117 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.97円で換算しております。
Back to Top
世界の髄膜炎菌ワクチン市場:2018年〜2025年 Global Meningococcal Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
出版日: 2018年09月11日 ページ情報: 英文 117 Pages
概要

当レポートでは、世界の髄膜炎菌ワクチン市場を調査し、市場の概要、製品タイプ・用途・地域/国別の売上量・収益額・価格の推移と予測(過去5年間・今後8年間分)、成長率、市場シェア、市場の成長要因、主要企業のプロファイルなど、包括的な情報を提供しています。

第1章 髄膜炎菌ワクチン市場の概要

  • 製品概要
  • 市場区分:製品タイプ
    • メナクトラ(Menactra)
    • メノミューン(Menomune)
  • 市場区分:用途別
    • 肺炎
    • 髄膜炎
    • 菌血症
    • その他(関節炎、結膜炎、尿道炎)
  • 調査目的
  • 調査対象期間

第2章 成長動向

  • 市場規模の推移と予測
    • 収益額の推移と予測
    • 売上量の推移と予測
  • 成長率の推移と予測:地域別
    • 売上量の推移と予測:地域別
    • 収益額の推移と予測:地域別
  • 産業動向
    • 主要動向
    • 成長要因

第3章 市場シェア:企業別

  • 売上量の推移と予測:企業別
  • 収益額の推移と予測:企業別
  • 価格動向:企業別
  • 主要企業の生産拠点/工場の分布、営業域
  • 主要企業の市場参入時期
  • 主要企業の製品
  • 合併・買収・事業拡大

第4章 髄膜炎菌ワクチン市場:製品タイプ別

  • 売上量と市場シェア:製品タイプ別
  • 収益額と市場シェア:製品タイプ別
  • 価格動向:製品タイプ別

第5章 髄膜炎菌ワクチン市場:用途別

  • 市場概要
  • 売上量:用途別

第6章 北米の髄膜炎菌ワクチン市場

  • 市場内訳:企業別
  • 市場内訳:製品タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の髄膜炎菌ワクチン市場

  • 市場内訳:企業別
  • 市場内訳:製品タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋の髄膜炎菌ワクチン市場

  • 市場内訳:企業別
  • 市場内訳:製品タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • インドネシア
    • マレーシア
    • フィリピン
    • タイ
    • ベトナム

第9章 中南米の髄膜炎菌ワクチン市場

  • 市場内訳:企業別
  • 市場内訳:製品タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • ブラジル

第10章 中東・アフリカの髄膜炎菌ワクチン市場

  • 市場内訳:企業別
  • 市場内訳:製品タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • 湾岸協力会議(GCC)
    • エジプト
    • 南アフリカ

第11章 企業プロファイル

  • Corning
  • Greiner Bio-One
  • Merck Millipore
  • Sartorius
  • Sigma-Aldrich
  • Thermo Fisher

第12章 世界の髄膜炎菌ワクチン市場の予測

  • 売上量と収益額の予測
  • 売上量の予測:製品タイプ別
  • 売上量の予測:用途別
  • 市場予測:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 中南米
  • 中東・アフリカ

第14章 調査結果と総論

第15章 付録

図表

List of Tables and Figures

  • Figure Meningococcal Vaccines Product Picture
  • Table Meningococcal Vaccines Key Market Segments
  • Table Major Manufacturers Meningococcal Vaccines Covered in This Report
  • Table Global Meningococcal Vaccines Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
  • Figure Global Meningococcal Vaccines Sales Market Shar by Type 2013-2025
  • Figure Menactra Figures
  • Table Global Meningococcal Vaccines Market Share by Application 2018-2025 (K Units)
  • Figure Pneumonia Use Case
  • Figure Meningococcal Vaccines Report Years Considered
  • Figure Global Meningococcal Vaccines Market Size 2013-2025 (Million US$)
  • Figure Global Meningococcal Vaccines Sales 2013-2018 (K Units)
  • Table Global Meningococcal Vaccines Market Size by Regions 2013-2018 (K Units) & (Million US$)
  • Table Global Meningococcal Vaccines Sales by Regions 2013-2018 (K Units)
  • Table Global Meningococcal Vaccines Sales Market Share by Regions 2013-2018
  • Figure Global Meningococcal Vaccines Sales Market Share by Regions 2013-2018
  • Figure Global Meningococcal Vaccines Sales Market Share by Regions in 2018
  • Table Global Meningococcal Vaccines Revenue by Regions 2013-2018 (Million US$)
  • Table Global Meningococcal Vaccines Revenue Market Share by Regions 2013-2018
  • Figure Global Meningococcal Vaccines Revenue Market Share by Regions 2013-2018
  • Figure Global Meningococcal Vaccines Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Meningococcal Vaccines Sales by Manufacturers (2013-2018) (K Units)
  • Table Global Meningococcal Vaccines Sales Share by Manufacturers (2013-2018)
  • Figure Global Meningococcal Vaccines Sales Share by Manufacturers in 2018
  • Table Meningococcal Vaccines Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Meningococcal Vaccines Revenue Share by Manufacturers (2013-2018)
  • Figure Meningococcal Vaccines Value Share by Manufacturers in 2018
  • Table Global Meningococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Meningococcal Vaccines Price (2013-2018) (USD/Unit)
  • Table Key Manufacturers Meningococcal Vaccines Plants/Factories Distribution
  • Table Key Manufacturers Meningococcal Vaccines Area Served
  • Table Date of Key Manufacturers Enter into Meningococcal Vaccines Market
  • Table Key Manufacturers Meningococcal Vaccines Product Type
  • Table Global Meningococcal Vaccines Sales by Type (2013-2018) (K Units)
  • Table Global Meningococcal Vaccines Sales Share by Type (2013-2018)
  • Figure Global Meningococcal Vaccines Sales Market Share by Type (2013-2018)
  • Figure Global Meningococcal Vaccines Sales Market Share by Type in 2017
  • Table Global Meningococcal Vaccines Revenue by Type (2013-2018) (Million US$)
  • Table Global Meningococcal Vaccines Revenue Share by Type (2013-2018)
  • Figure Global Meningococcal Vaccines Revenue Market Share by Type (2013-2018)
  • Figure Global Meningococcal Vaccines Revenue Market Share by Type in 2017
  • Table Meningococcal Vaccines Price by Type 2013-2018 (USD/Unit)
  • Table Global Meningococcal Vaccines Sales by Application (2013-2018) (K Units)
  • Table Global Meningococcal Vaccines Sales Share by Application (2013-2018)
  • Figure Global Sales Meningococcal Vaccines Market Share by Application (2013-2018)
  • Figure Global Sales Meningococcal Vaccines Market Share by Application in 2017
  • Figure North America Meningococcal Vaccines Sales Growth Rate 2013-2018 (K Units)
  • Figure North America Meningococcal Vaccines Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America Meningococcal Vaccines Sales by Company (2013-2018) (K Units)
  • Table North America Meningococcal Vaccines Sales Market Share by Company (2013-2018)
  • Figure North America Meningococcal Vaccines Sales Market Share by Company in 2018
  • Table North America Meningococcal Vaccines Sales by Type (2013-2018) (K Units)
  • Table North America Meningococcal Vaccines Sales Market Share by Type (2013-2018)
  • Figure North America Meningococcal Vaccines Market Share by Type in 2018
  • Table North America Meningococcal Vaccines Sales by Application (2013-2018) (K Units)
  • Table North America Meningococcal Vaccines Sales Market Share by Application (2013-2018)
  • Figure North America Meningococcal Vaccines Market Share by Application in 2018
  • Table North America Meningococcal Vaccines Sales by Countries (2013-2018) (K Units)
  • Table North America Meningococcal Vaccines Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America Meningococcal Vaccines Sales Market Share by Countries
  • Table North America Meningococcal Vaccines Revenue by Countries (2013-2018) (Million US$)
  • Table North America Meningococcal Vaccines Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America Meningococcal Vaccines Revenue Market Share by Countries
  • Figure United States Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Canada Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Mexico Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Europe Meningococcal Vaccines Sales Growth Rate 2013-2018 (K Units)
  • Figure Europe Meningococcal Vaccines Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe Meningococcal Vaccines Sales by Company (2013-2018) (K Units)
  • Table Europe Meningococcal Vaccines Sales Market Share by Company (2013-2018)
  • Figure Europe Meningococcal Vaccines Sales Market Share by Company in 2018
  • Table Europe Meningococcal Vaccines Sales by Type (2013-2018) (K Units)
  • Table Europe Meningococcal Vaccines Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe Meningococcal Vaccines Market Share by Type
  • Table Europe Meningococcal Vaccines Sales by Application (2013-2018) (K Units)
  • Table Europe Meningococcal Vaccines Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe Meningococcal Vaccines Market Share by Application
  • Table Europe Meningococcal Vaccines Sales by Countries (2013-2018) (K Units)
  • Table Europe Meningococcal Vaccines Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Meningococcal Vaccines Sales Market Share by Countries
  • Table Europe Meningococcal Vaccines Revenue by Countries (2013-2018) (Million US$)
  • Table Europe Meningococcal Vaccines Revenue Market Share by Countries (2013-2018)
  • Figure Europe Meningococcal Vaccines Revenue Market Share by Countries in 2018
  • Figure Germany Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure France Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure UK Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Italy Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Russia Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Asia Pacific Meningococcal Vaccines Sales Growth Rate 2013-2018 (K Units)
  • Figure Asia Pacific Meningococcal Vaccines Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific Meningococcal Vaccines Sales by Company (2013-2018) (K Units)
  • Table Asia Pacific Meningococcal Vaccines Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific Meningococcal Vaccines Sales Market Share by Company in 2018
  • Table Asia Pacific Meningococcal Vaccines Sales by Type (2013-2018) (K Units)
  • Table Asia Pacific Meningococcal Vaccines Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific Meningococcal Vaccines Market Share by Type in 2018
  • Table Asia Pacific Meningococcal Vaccines Sales by Application (2013-2018) (K Units)
  • Table Asia Pacific Meningococcal Vaccines Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific Meningococcal Vaccines Market Share by Application in 2018
  • Table Asia Pacific Meningococcal Vaccines Sales by Countries (2013-2018) (K Units)
  • Table Asia Pacific Meningococcal Vaccines Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Meningococcal Vaccines Sales Market Share by Countries
  • Table Asia Pacific Meningococcal Vaccines Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific Meningococcal Vaccines Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Meningococcal Vaccines Revenue Market Share by Countries
  • Figure China Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure China Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Japan Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Korea Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure India Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Australia Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Indonesia Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Malaysia Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Philippines Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Thailand Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Vietnam Meningococcal Vaccines Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America Meningococcal Vaccines Sales Growth Rate 2013-2018 (K Units)
  • Figure Central & South America Meningococcal Vaccines Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America Meningococcal Vaccines Sales by Company (2013-2018) (K Units)
  • Table Central & South America Meningococcal Vaccines Sales Market Share by Company (2013-2018)
  • Figure Central & South America Meningococcal Vaccines Sales Market Share by Company in 2018
  • Table Central & South America Meningococcal Vaccines Sales by Type (2013-2018) (K Units)
  • Table Central & South America Meningococcal Vaccines Sales Market Share by Type (2013-2018)
  • Figure Central & South America Meningococcal Vaccines Market Share by Type in 2018
  • Table Central & South America Meningococcal Vaccines Sales by Application (2013-2018) (K Units)
  • Table Central & South America Meningococcal Vaccines Sales Market Share by Application (2013-2018)
  • Figure Central & South America Meningococcal Vaccines Market Share by Application in 2018
  • Table Central & South America Meningococcal Vaccines Sales by Countries (2013-2018) (K Units)
  • Table Central & South America Meningococcal Vaccines Sales Market Share by Countries (2013-2018)
  • Figure Central & South America Meningococcal Vaccines Sales Market Share by Countries in 2018
  • Table Central & South America Meningococcal Vaccines Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America Meningococcal Vaccines Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America Meningococcal Vaccines Revenue Market Share by Countries in 2018
  • Figure Brazil Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Brazil Meningococcal Vaccines Revenue Growth Rate (2013-2018) (K Units)
  • Figure Middle East and Africa Meningococcal Vaccines Sales Growth Rate 2013-2018 (K Units)
  • Figure Middle East and Africa Meningococcal Vaccines Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa Meningococcal Vaccines Sales by Type (2013-2018) (K Units)
  • Table Middle East and Africa Meningococcal Vaccines Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Meningococcal Vaccines Market Share by Type
  • Table Middle East and Africa Meningococcal Vaccines Sales by Application (2013-2018) (K Units)
  • Table Middle East and Africa Meningococcal Vaccines Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Meningococcal Vaccines Market Share by Application
  • Table Middle East and Africa Meningococcal Vaccines Sales by Countries (2013-2018) (K Units)
  • Table Middle East and Africa Meningococcal Vaccines Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Meningococcal Vaccines Sales Market Share by Countries
  • Table Middle East and Africa Meningococcal Vaccines Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa Meningococcal Vaccines Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Meningococcal Vaccines Revenue Market Share by Countries
  • Figure GCC Countries Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure GCC Countries Meningococcal Vaccines Revenue Growth Rate (2013-2018) (K Units)
  • Figure Egypt Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure Egypt Meningococcal Vaccines Revenue Growth Rate (2013-2018) (K Units)
  • Figure South Africa Meningococcal Vaccines Sales Growth Rate (2013-2018) (K Units)
  • Figure South Africa Meningococcal Vaccines Revenue Growth Rate (2013-2018) (K Units)
  • Table GlaxoSmithKline Company Details
  • Table GlaxoSmithKline Description and Business Overview
  • Table GlaxoSmithKline Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table GlaxoSmithKline Meningococcal Vaccines Sales Growth Rate (2013-2018)
  • Table GlaxoSmithKline Meningococcal Vaccines Sales Market Share in Global Market
  • Table GlaxoSmithKline Recent Development
  • Table JN-International Medical Company Details
  • Table JN-International Medical Description and Business Overview
  • Table JN-International Medical Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table JN-International Medical Meningococcal Vaccines Sales Growth Rate (2013-2018)
  • Table JN-International Medical Meningococcal Vaccines Sales Market Share in Global Market
  • Table JN-International Medical Recent Development
  • Table Novartis International Company Details
  • Table Novartis International Description and Business Overview
  • Table Novartis International Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Novartis International Meningococcal Vaccines Sales Growth Rate (2013-2018)
  • Table Novartis International Meningococcal Vaccines Sales Market Share in Global Market
  • Table Novartis International Recent Development
  • Table Sanofi Company Details
  • Table Sanofi Description and Business Overview
  • Table Sanofi Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Sanofi Meningococcal Vaccines Sales Growth Rate (2013-2018)
  • Table Sanofi Meningococcal Vaccines Sales Market Share in Global Market
  • Table Sanofi Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Description and Business Overview
  • Table Pfizer Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Pfizer Meningococcal Vaccines Sales Growth Rate (2013-2018)
  • Table Pfizer Meningococcal Vaccines Sales Market Share in Global Market
  • Table Pfizer Recent Development
  • Table Baxter International Company Details
  • Table Baxter International Description and Business Overview
  • Table Baxter International Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Meningococcal Vaccines Value Chain
  • Table Meningococcal Vaccines Distributors List
  • Table Meningococcal Vaccines Customers List
  • Table Global Meningococcal Vaccines Sales Forecast 2018-2025 (K Units) & (Million US$)
  • Figure Global Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Global Meningococcal Vaccines Revenue Forecast 2018-2025 (Million US$)
  • Table Global Meningococcal Vaccines Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Meningococcal Vaccines Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Meningococcal Vaccines Sales Market Share Forecast by Type 2018-2025
  • Table Global Meningococcal Vaccines Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Meningococcal Vaccines Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Meningococcal Vaccines Sales Market Share Forecast by Application 2018-2025
  • Table Global Meningococcal Vaccines Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Meningococcal Vaccines Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Meningococcal Vaccines Sales Market Share Forecast by Regions 2018-2025
  • Table Global Meningococcal Vaccines Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Meningococcal Vaccines Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Meningococcal Vaccines Revenue Market Share Forecast by Regions 2018-2025
  • Table North America Meningococcal Vaccines Sales Forecast by Countries 2018-2025 (K Units)
  • Table North America Meningococcal Vaccines Sales Market Share Forecast by Countries 2018-2025
  • Table North America Meningococcal Vaccines Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America Meningococcal Vaccines Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Canada Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure MexicoMeningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Table Europe Meningococcal Vaccines Sales Forecast by Countries 2018-2025 (K Units)
  • Table Europe Meningococcal Vaccines Sales Market Share Forecast by Countries 2018-2025
  • Table Europe Meningococcal Vaccines Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe Meningococcal Vaccines Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure France Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure UK Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Italy Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Russia Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Table Asia Pacific Meningococcal Vaccines Sales Forecast by Countries 2018-2025 (K Units)
  • Table Asia Pacific Meningococcal Vaccines Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific Meningococcal Vaccines Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific Meningococcal Vaccines Revenue Market Share Forecast by Countries 2018-2025
  • Figure China Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Japan Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Korea Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure India Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Australia Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Indonesia Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Thailand Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Malaysia Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Philippines Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Figure Vietnam Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Table Central & South America Meningococcal Vaccines Sales Forecast by Countries 2018-2025 (K Units)
  • Table Central & South America Meningococcal Vaccines Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America Meningococcal Vaccines Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America Meningococcal Vaccines Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil Meningococcal Vaccines Sales Forecast 2018-2025 (K Units)
  • Table Middle East and Africa Meningococcal Vaccines Sales Forecast by Regions 2018-2025 (K Units)
  • Table Middle East and Africa Meningococcal Vaccines Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa Meningococcal Vaccines Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa Meningococcal Vaccines Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
  • Figure Egypt Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
  • Figure South Africa Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
目次

This study researches the market size of Meningococcal Vaccines, presents the global Meningococcal Vaccines sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Meningococcal Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Meningococcal Vaccines for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2018, the global Meningococcal Vaccines market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Meningococcal Vaccines.

This report includes the following manufacturers; we can also add the other companies as you want.

  • GlaxoSmithKline
  • JN-International Medical
  • Novartis International
  • Sanofi
  • Pfizer
  • Baxter International
  • ...

Market Segment by Product Type

  • Menactra
  • Menomune

Market Segment by Application

  • Pneumonia
  • Meningitis
  • Bacteremia
  • Others (Arthritis, Conjunctivitis, Urethritis)

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Meningococcal Vaccines status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Meningococcal Vaccines manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Meningococcal Vaccines are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
  • 1.4. Market Segment by Application
    • 1.4.1. Global Meningococcal Vaccines Market Share by Application (2018-2025)
    • 1.4.2. Pneumonia
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global Meningococcal Vaccines Market Size
    • 2.1.1. Global Meningococcal Vaccines Revenue 2013-2025
    • 2.1.2. Global Meningococcal Vaccines Sales 2013-2025
  • 2.2. Meningococcal Vaccines Growth Rate by Regions
    • 2.2.1. Global Meningococcal Vaccines Sales by Regions 2013-2018
    • 2.2.2. Global Meningococcal Vaccines Revenue by Regions 2013-2018
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. Meningococcal Vaccines Sales by Manufacturers
    • 3.1.1. Meningococcal Vaccines Sales by Manufacturers 2013-2018
    • 3.1.2. Meningococcal Vaccines Sales Market Share by Manufacturers 2013-2018
  • 3.2. Revenue by Manufacturers
    • 3.2.1. Meningococcal Vaccines Revenue by Manufacturers (2013-2018)
    • 3.2.2. Meningococcal Vaccines Revenue Share by Manufacturers (2013-2018)
    • 3.2.3. Global Meningococcal Vaccines Market Concentration Ratio (CR5 and HHI)
  • 3.3. Meningococcal Vaccines Price by Manufacturers
  • 3.4. Key Manufacturers Meningococcal Vaccines Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into Meningococcal Vaccines Market
  • 3.6. Key Manufacturers Meningococcal Vaccines Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.2. Global Meningococcal Vaccines Sales Market Share by Type
  • 4.3. Global Meningococcal Vaccines Revenue Market Share by Type
  • 4.4. Meningococcal Vaccines Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global Meningococcal Vaccines Sales by Application

6. North America

  • 6.1. North America Meningococcal Vaccines Breakdown Data by Company
  • 6.2. North America Meningococcal Vaccines Breakdown Data by Type
  • 6.3. North America Meningococcal Vaccines Breakdown Data by Application
  • 6.4. North America Meningococcal Vaccines Breakdown Data by Countries
    • 6.4.1. North America Meningococcal Vaccines Sales by Countries
    • 6.4.2. North America Meningococcal Vaccines Revenue by Countries
    • 6.4.3. United States
    • 6.4.4. Canada
    • 6.4.5. Mexico

7. Europe

  • 7.1. Europe Meningococcal Vaccines Breakdown Data by Company
  • 7.2. Europe Meningococcal Vaccines Breakdown Data by Type
  • 7.3. Europe Meningococcal Vaccines Breakdown Data by Application
  • 7.4. Europe Meningococcal Vaccines Breakdown Data by Countries
    • 7.4.1. Europe Meningococcal Vaccines Sales by Countries
    • 7.4.2. Europe Meningococcal Vaccines Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. UK
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Meningococcal Vaccines Breakdown Data by Company
  • 8.2. Asia Pacific Meningococcal Vaccines Breakdown Data by Type
  • 8.3. Asia Pacific Meningococcal Vaccines Breakdown Data by Application
  • 8.4. Asia Pacific Meningococcal Vaccines Breakdown Data by Countries
    • 8.4.1. Asia Pacific Meningococcal Vaccines Sales by Countries
    • 8.4.2. Asia Pacific Meningococcal Vaccines Revenue by Countries
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Indonesia
    • 8.4.9. Malaysia
    • 8.4.10. Philippines
    • 8.4.11. Thailand
    • 8.4.12. Vietnam

9. Central & South America

  • 9.1. Central & South America Meningococcal Vaccines Breakdown Data by Company
  • 9.2. Central & South America Meningococcal Vaccines Breakdown Data by Type
  • 9.3. Central & South America Meningococcal Vaccines Breakdown Data by Application
  • 9.4. Central & South America Meningococcal Vaccines Breakdown Data by Countries
    • 9.4.1. Central & South America Meningococcal Vaccines Sales by Countries
    • 9.4.2. Central & South America Meningococcal Vaccines Revenue by Countries
    • 9.4.3. Brazil

10. Middle East and Africa

  • 10.1. Middle East and Africa Meningococcal Vaccines Breakdown Data by Type
  • 10.2. Middle East and Africa Meningococcal Vaccines Breakdown Data by Application
  • 10.3. Middle East and Africa Meningococcal Vaccines Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Meningococcal Vaccines Sales by Countries
    • 10.3.2. Middle East and Africa Meningococcal Vaccines Revenue by Countries
    • 10.3.3. GCC Countries
    • 10.3.4. Egypt
    • 10.3.5. South Africa

11. Company Profiles

  • 11.1. GlaxoSmithKline
    • 11.1.1. GlaxoSmithKline Company Details
    • 11.1.2. Company Description and Business Overview
    • 11.1.3. Sales, Revenue and Market Share of Meningococcal Vaccines
    • 11.1.4. Meningococcal Vaccines Product Introduction
    • 11.1.5. GlaxoSmithKline Recent Development
  • 11.2. JN-International Medical
    • 11.2.1. JN-International Medical Company Details
    • 11.2.2. Company Description and Business Overview
    • 11.2.3. Sales, Revenue and Market Share of Meningococcal Vaccines
    • 11.2.4. Meningococcal Vaccines Product Introduction
    • 11.2.5. JN-International Medical Recent Development
  • 11.3. Novartis International
    • 11.3.1. Novartis International Company Details
    • 11.3.2. Company Description and Business Overview
    • 11.3.3. Sales, Revenue and Market Share of Meningococcal Vaccines
    • 11.3.4. Meningococcal Vaccines Product Introduction
    • 11.3.5. Novartis International Recent Development
  • 11.4. Sanofi
    • 11.4.1. Sanofi Company Details
    • 11.4.2. Company Description and Business Overview
    • 11.4.3. Sales, Revenue and Market Share of Meningococcal Vaccines
    • 11.4.4. Meningococcal Vaccines Product Introduction
    • 11.4.5. Sanofi Recent Development
  • 11.5. Pfizer
    • 11.5.1. Pfizer Company Details
    • 11.5.2. Company Description and Business Overview
    • 11.5.3. Sales, Revenue and Market Share of Meningococcal Vaccines
    • 11.5.4. Meningococcal Vaccines Product Introduction
    • 11.5.5. Pfizer Recent Development
  • 11.6. Baxter International
    • 11.6.1. Baxter International Company Details
    • 11.6.2. Company Description and Business Overview

12. Value Chain and Sales Channels Analysis

  • 12.1. Value Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Meningococcal Vaccines Sales Channels
    • 12.2.2. Meningococcal Vaccines Distributors
  • 12.3. Meningococcal Vaccines Customers

13. Market Forecast

  • 13.1. Global Meningococcal Vaccines Sales and Revenue Forecast 2018-2025
  • 13.2. Global Meningococcal Vaccines Sales Forecast by Type
  • 13.3. Global Meningococcal Vaccines Sales Forecast by Application
  • 13.4. Meningococcal Vaccines Forecast by Regions
    • 13.4.1. Global Meningococcal Vaccines Sales Forecast by Regions 2018-2025
    • 13.4.2. Global Meningococcal Vaccines Revenue Forecast by Regions 2018-2025
  • 13.5. North America Market Forecast
    • 13.5.1. North America Meningococcal Vaccines Forecast by Countries 2018-2025
    • 13.5.2. United States
    • 13.5.3. Canada
    • 13.5.4. Mexico
  • 13.6. Europe Market Forecast
    • 13.6.1. Europe Meningococcal Vaccines Forecast by Countries 2018-2025
    • 13.6.2. Germany
    • 13.6.3. France
    • 13.6.4. UK
    • 13.6.5. Italy
    • 13.6.6. Russia
  • 13.7. Asia Pacific Market Forecast
    • 13.7.1. Asia Pacific Meningococcal Vaccines Sales Forecast by Countries 2018-2025
    • 13.7.2. China
    • 13.7.3. Japan
    • 13.7.4. Korea
    • 13.7.5. India
    • 13.7.6. Australia
    • 13.7.7. Indonesia
    • 13.7.8. Thailand
    • 13.7.9. Malaysia
    • 13.7.10. Philippines
    • 13.7.11. Vietnam
  • 13.8. Central & South America Market Forecast
    • 13.8.1. Central & South America Meningococcal Vaccines Sales Forecast by Countries 2018-2025
    • 13.8.2. Brazil
  • 13.9. Middle East and Africa Market Forecast
    • 13.9.1. Middle East and Africa Meningococcal Vaccines Sales Forecast by Countries 2018-2025
    • 13.9.2. GCC Countries
    • 13.9.3. Egypt
    • 13.9.4. South Africa

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 13.1.2.2. Primary Sources
  • 15.2. Author Details
  • 15.3. Disclaimer
Back to Top